Recall Register

Food, drugs, devices › bioMerieux, Inc.

Device recall: VITEK 2 card AST-N371 - Product Usage: The VITEK 2 is an automated system consisting of instruments, software, and reage

FDA enforcement event 84993 · Class II · initiated 5 Feb 2020 · status Terminated · terminated 28 Oct 2022

DeviceVoluntary: Firm initiated1 product recordDurham, NC

bioMerieux, Inc. (Durham, NC) initiated this device recall on 5 Feb 2020; FDA lists 1 product record under event 84993, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 916 device enforcement events initiated in 2020 carry the same class.

Status: Terminated, terminated 28 Oct 2022. Initiation: voluntary: firm initiated. bioMerieux, Inc. has 57 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

bioMerieux, Inc., Durham, NC.

Reason for recall

"The top seal of some of the pouches was compromised which can allow moisture to enter that can impact some antibiotics on the card."

Distribution

"International distribution in the countries of Germany and the Netherlands."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1534-2020VITEK 2 card AST-N371 - Product Usage: The VITEK 2 is an automated system consisting of instruments, software, and reagent cards designed for the identification and antimicrobial susceptibility testing of bacteria and yeast. The VITEK 2 utilizes growth-based biochemical patterns to determine identification. The VITEK…4,130 kits (82,600 cards)Class IITerminated1 Apr 2020

Context

93%of 2020 device events are Class II916 events that year
1product record in this eventfirm median: 1
57events on this register for the firm

Other enforcement events for bioMerieux, Inc.

InitiatedProduct (first record)TypeClassRecords
4 Jun 2026VITEK 2 AST-N447 TEST KIT Product reference 424620DeviceClass II1
5 Jan 2026VITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza02n) o MeropenemDeviceClass II1
26 Jun 2025VITEK¿ 2 Gram-negative AST Test Kits (Cards) containing Colistin formulation cs02n. VITEK¿ 2 is an automated system consDeviceClass II1
14 Mar 2024VITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REF 418984; b) ADeviceClass I1
6 Feb 2023MYLA comprises AST Filters in conjunction with VITEK MS; middleware which connects microbiology laboratory instruments fDeviceClass II1
9 Nov 2022API LISTERIA 10 STRIPS+10 MEDIA, CATALOG 10300DeviceClass II94
20 Jul 2022NUCLISENS easyMAG Magnetic Silica, REF 280133, 24 x 1.2mL bottles/kit.DeviceClass II1
13 Jul 2022VITEK 2 / MYLA VITEK 2 Software versions 8.01, 8.02 (veterinary use only), 9.01, 9.02, 9.03 MYLA Software versions V4.8 DeviceClass II1
29 Mar 2022VITEK 2 Systems and VITEK 2 with MYLA.DeviceClass II1
9 Feb 2022VIDAS CMV IgM, 30 tests, REF 30205-01, IVD, Rx.DeviceClass II1

All 57 events for bioMerieux, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The top seal of some of the pouches was compromised which can allow moisture to enter that can impact some antibiotics on the card."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "International distribution in the countries of Germany and the Netherlands."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 28 Oct 2022. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.